IP Library › Patent Application 63365371
Patent Application Provisional
App. No. 63/365,371 · Confirmation No. 9340

ANTI-TNFR2 ANTIBODIES AND METHODS OF USE THEREOF

Applicant: Pfizer Inc.
Provisional Application Expired
⬇ PDF
 Code Description Pages PDF
2023-05-16 OATH Oath or Declaration filed 4 View
2023-04-27 APP.FILE.REC Filing Receipt 3 View
2023-04-27 R48.REQ.G Acceptance of Request under Rule 48 to correct inventorship or name 1 View
2023-04-24 R48.REQ Request under Rule 48 correcting inventorship 3 View
2023-04-24 N417.PYMT Electronic Fee Payment 2 View
2023-04-24 ADS Application Data Sheet 9 View
2023-04-24 N417 Electronic Filing System Acknowledgment Receipt 2 View
2022-06-30 APP.FILE.REC Filing Receipt 3 View
2022-06-28 PEFR Applicant Response to Pre-Exam Formalities Notice 2 View
2022-06-28 N417 Electronic Filing System Acknowledgment Receipt 2 View
2022-06-28 N417.PYMT Electronic Fee Payment 2 View
2022-06-28 PEFR Applicant Response to Pre-Exam Formalities Notice 2 View
2022-06-07 NTC.MISS.PRT Notice to File Missing Parts 2 View
2022-06-07 APP.FILE.REC Filing Receipt 3 View
2022-05-26 DRW Drawings-only black and white line drawings 2 View
2022-05-26 N417 Electronic Filing System Acknowledgment Receipt 2 View
2022-05-26 ADS Application Data Sheet 8 View
2022-05-26 SPEC Specification 68 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
63/365,371
Filed
2022-05-26